Annual gsdm camp2014 Health Group

NORIKO MORIOKA | AYAKO MATSUURA | ANJAR DIMARA SAKTI | SUHIMO NAKATSU | SHOHEI HODOTA | TAKU MONJO

Project PresentationSunday, 23 March 2014

Sharon Village

STRATEGY OF EFFICIENT VACCINE DISTRIBUTION IN JAPAN

Global Leader Program for Social Design and Management

Pandemic Influenza

What is influenza?

• occur when a non-human influenza virus gains the ability for efficient and sustained human-to-human transmission and then spreads globally.

INTRODUCTION ABOUT THE VIRUSES

Pandemic

• It is an acute respiratory disorder caused by influenza virus.

• Two types of influenza: Seasonal vs. Pandemic

• Influenza viruses with pandemic potential:

H5N1, H7N9 etc.

What happened on 2009?

A new type of H1N1 virus emerged in April 2009

About 170000 people were infected in Japan by November 2009

No framework about distribution of vaccines before.

Imbalance in demand and supply of vaccine

- The vaccines were not delivered to the right region

- Surplus of the vaccines

http://www.cas.go.jp/jp/seisaku/ful/keikaku/pdf/gl_guideline.pdf

Surveillance and

Information Provision and

Sharing

Prevention Medical System

Maintaining social activityVaccination

OVERVIEW: Guideline for Prevention and Control of Pandemic Influenza In Japan

The Ministry of Health, Labor and Welfare shall deliver vaccines in multiple phases to individual vaccination locations through wholesalers etc., according to the doses requested by each agency and prefectural government.

http://www.cas.go.jp/jp/seisaku/ful/keikaku/pdf/gl_guideline.pdf

Municipality

Prefecture

The Ministry of Health, Labor and Welfare

Request the dose of vaccines

Decide the allocation of vaccines according the amount of request, pandemic situations, demographics in each area

wholesalers

Delivering vaccines

Hospitals & clinics

Strategy for allocation of vaccines

Vaccine Management Business Improvement project (2003)

-Centralized Vaccine Distribution(2008) -Vaccine Tracking System(2013) -National Pediatric Vaccine Stockpile CDC (http://www.cdc.gov/vaccines/programs/vmbip/index.html)

Situation and efforts in U.S.

Centralized Distribution; Deliver Vaccines Directly to Providers

By 2008, CDC had successfully transitioned all 64 awardee health departments from a dispersed model (where they managed their own distribution and 430+ storage depots) to a centralized model (leveraging one private distributor with two national depots) to deliver vaccines directly to providers. The benefits of this change include reduced inventory costs, distribution contract savings, and decreased vaccine wastage.

Vaccine Distribution Contract Between CDC and McKesson Specialty, Inc.

Improve CDC’s Financial Control of National Vaccine Distribution Costs, Reduce High Vaccine Waste and Save money

Centralized Vaccine Distribution

a secure, web-based information technology system that integrates the entire publicly-funded vaccine supply chain from purchasing and ordering through distribution to participating state, local, and territorial health departments (referred to as 'awardees') and health care providers.

VTrckS was launched at four pilot awardee sites in December 2010; the phased roll-out of the system to all 64 awardees was completed in May 2013.

Vaccine Tracking System

VTrckS

VOFA

VACMAN

NIPVAC

Benefits; Not only easy to track, make it much faster, cheaperBut also can easily accumulate and centralize data

Vaccine Tracking System

OBJECTIVE

To develop a Integrated system to help decision makers to provide accurate information about the Multiple Scenario Services and Pre-analysis about distribution of vaccine.

IMPROVING OF JAPAN HEALTH POLICY

Assumed circumstancesPandemic of highly pathogenic influenza virus in Japan

ACTINGDECISION MAKINGINTEGRATED SYSTEM

Application Development

Collaboration with other

perspectives

Management of Health

Epidemiological Studies

Health Policy

Information Technology

Geospatial System

Strategy: Integrated System

[DISTRIBUTION]

(SURVEILLANCE)

HEALTH INFORMATION DATA CENTER POSITION IN THE USER INTERACTION WITH STAKEHOLDER

VACCINE DISTRIBUTION MANAGEMENTMULTI LAYER MODEL

Distribution of Vaccine

Pandemic Prediction

Demography

Hospital & Health Center

Surveillance (patient)

CENTERRALIZATION NIID

VACCINE COMPANY

LOCAL GOVERNMENT- Location of Hospital, school

- Population

HOSPITAL AGENCY

MHLW

HEALTH CENTER

Implementation System in HealthManagement

Prediction

Vaccine distribution

Demographic

Public facilities

Surveillance

Multi Layer Model

Transportation

System(MHLW)Hospital

Agent

RegionalGovernment

Manufacture

NIID

Centralization

: Information flow

Parameter :

Infected Point

Pandemic Population

Transportation Network

Location of Public Facilities

Recommended area to distribute vaccine

GEOSPATIAL ACTIVITIES

APPLICATION OF GIS TO IDENTIFY PANDEMIC AREA DISTRIBUTION

PLANNINGMAPPING

ANALYZINGGEO-DATABASE

VISUALIZING

GEOSPATIAL ACTIVITIES

GEO-MONITORING

STAKEHOLDER -The system would affect the interest of some actors

The supplier of information from surveillance Hospitals　　 Health Center Manufacture Wholesale NIID(National Institute of Infectious Diseases, Japan)

←could need initial investment, but the burden is not highly different from the usual surveillance The receiver of information; need to organize Ministry of Health Labor and Welfare NIID

←fairly ameliorated by the scandalized format and cloud computing

Centralized Information ⇒ Vulnerability

Personal Information ProtectionSide Effect

Quality assurance (When Needed)

For implementation

For Faster, Safer and more effective way to deliver the

vaccine

ARIGATOU GOZAIMASU